Supriya Lifescience Limited Cash Flow Quality Index
Supriya Lifescience Limited cash flow quality index. Supriya Lifescience Limited (SUPRIYA) has a Cash Flow Quality Index of 0.65x as of September 2025. Operating cash flow of Rs555.65 Million is below net income of Rs852.17 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of Supriya Lifescience Limited to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Supriya Lifescience Limited (2018–2025)
Cash flow quality index of Supriya Lifescience Limited from 2018 to 2025. Historical Cash Flow Quality Index for Supriya Lifescience Limited across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Supriya Lifescience Limited cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Supriya Lifescience Limited Cash Flow Quality Index by Year (2018–2025)
Supriya Lifescience Limited cash flow quality index by year from 2018 to 2025. Year-by-year earnings quality comparison for Supriya Lifescience Limited. For the full cash flow conversion analysis, see SUPRIYA cash generation efficiency.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.92x | Rs1.73 Billion | Rs1.88 Billion | ▼ -3.5% |
| 2024 | 0.95x | Rs1.13 Billion | Rs1.19 Billion | ▲ +77.5% |
| 2023 | 0.54x | Rs661.87 Million | Rs1.23 Billion | ▲ +127.6% |
| 2022 | 0.24x | Rs488.01 Million | Rs2.07 Billion | ▼ -50.7% |
| 2021 | 0.48x | Rs799.30 Million | Rs1.67 Billion | ▼ -60.4% |
| 2020 | 1.21x | Rs1.16 Billion | Rs962.27 Million | ▲ +41.5% |
| 2019 | 0.85x | Rs486.72 Million | Rs571.04 Million | ▼ -57.4% |
| 2018 | 2.00x | Rs174.52 Million | Rs87.28 Million | — |